Board Meeting25 May 2026, 07:41 pm
Norris Medicines Board Meeting on May 30, 2026
AI Summary
Norris Medicines Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The meeting will also address any other business with the permission of the Chair and the consent of the Directors. The trading window for dealing in the company's securities is closed from April 1, 2026, until 48 hours after the declaration of the financial results.
Key Highlights
- Board meeting scheduled for May 30, 2026, to approve audited financial results.
- Financial results are for the quarter and year ended March 31, 2026.
- Trading window closed from April 1, 2026, until 48 hours post results declaration.
- Meeting to be held at the company's registered office in Ankleshwar, Gujarat.
Price Impact
More from NORRIS